Because of its investigational status, retatrutide should not be viewed as an alternative that is automatically available or suitable
Ozempic reduces the number of adverse cardiovascular events and improves renal outcomes
Novo Nordisk produces semaglutide under the brand names Ozempic, Wegovy, and Rybelsus
Pharmacological synergistic effects of SGLT2 inhibitors in DKD therapy Monotherapy with metformin, insulin or pioglitazone alone is poorly effective in maintaining long-term glycemic control and renoprotection in a majority of patients with DKD [41]
Fractyl Health Reports Positive One-Year REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita Procedure Participants retained ~78% of GLP-1 induced total body weight loss one year after discontinuation and a single Revita procedure 5.3% mean weight change observed with Revita (n=15)
Effective weight loss treatments are those that are grounded in rigorous scientific research, having undergone peer-reviewed studies that demonstrate their safety and efficacy